
Periodic Insights: December 2025 Edition
This month we’re zooming out and zooming in—looking at the molecular strategies shaping next-gen therapeutics, from peptides and PROTACs to ADMET modeling and AI-guided antibodies. We’re also exploring the chemistry behind GLP-1 innovation and the emerging debate around quantum computing’s role in R&D. Here’s what caught our eye.
Feature Story
Harnessing Nature: The Rise of Peptide Therapeutics
Peptide drugs are entering a renaissance, powered by new tools in synthesis, purification, and design—this on-demand session explores how modern chemistry platforms make peptide development faster, more scalable, and more predictable for R&D teams.
Inside the Lab
- Explore how proprietary experimental datasets strengthen predictive models in our look at ADMET modeling beyond public data. (White Paper)
- See how chemists are simplifying targeted protein degradation workflows through high-throughput PROTAC synthesis. (Technical Article)
- Learn how heavy main-group elements are reshaping catalytic chemistry in this overview of bismuth catalysis at the frontiers of the periodic table. (Webinar)
From the Field
- Quantum algorithms are evolving fast — and C&EN asks whether quantum computing may become chemistry's next AI. (C&EN)
- Generative modeling is pushing into biologics with AI systems that design antibodies at near-atomic precision. (Chemistry World)
- As GLP-1 agonists continue to dominate the scientific conversation, Nature explores whether GLP-1s could represent the first longevity drugs. (Nature Biotechnology)
Events
- Dec 1-3, Winter Process Chemistry 2025 (Manchester, UK)
- Dec. 4-5, MOCS 2025 (Blankenberge, Belgium)
- Jan 15-17, SMARTCHEM 2026 (Bengaluru, India)
Product Spotlight
Building Blocks, Resins & Coupling Reagents for GLP-1 Synthesis
As GLP-1–based therapies expand, chemists need dependable components for fast, reproducible peptide assembly; this collection brings the essentials into one place.